Psoriasis is a very common skin disorder in which people develop pink thick plaques with silvery scale on elbows, knees, scalp and arms, but some people have this disease all over their body. A common misconception is that psoriasis is only a skin disease, but it can cause systemic inflammation and an inflammatory arthritis called psoriatic arthritis. Patients with psoriasis have a higher risk of cardiovascular disease. For these reasons, it is important that patients with psoriasis seek evaluation of their disease. Aside from topical steroids and phototherapy, there are increasingly new and effective treatments for psoriasis. Dr. Flanagan has a special interest in psoriasis due to her training in both internal medicine and general medical dermatology which allows her comfort in all the newest psoriasis treatments. Dr. Flanagan has experience with biological therapies such as Humira, Enbrel, Cosentyx, Stelara as well as Otezla, methotrexate and cyclosporin. She is dedicated to explaining the different therapeutic options for psoriasis and customizes medical regimens based on the patient’s type of psoriasis and treatment goals. The newer medications for psoriasis have made it possible to achieve almost complete clearance of psoriasis from the skin. These newer medications are been tested extensively and are safe and well tolerated. Dr. Flanagan is anxious to extend access to these new medications to the many patients living with psoriasis who are ready to get clear of their skin disease.